Rare diseases
Investigational molecules
Locations
Groenland 32, 3045 Drammen, Norway
Clinical research at Vestre Viken HF includes treatment of EGFR-mutated non-small cell lung cancer, with interest in first-line targeted therapy and associated biological sampling.
The focus reflects active involvement in molecularly defined lung cancer care in the advanced oncology setting.
Vestre Viken HF runs clinical trials in conditions such as Non-small cell lung cancer, Coronary artery disease, EGFR gene mutation, Perioperative analgesia, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
Norway
LithuaniaNorway
DenmarkNorwayIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
